News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
868,175 Results
Type
Article (87832)
Company Profile (824)
Press Release (779505)
Multimedia
Podcasts (189)
Webinars (28)
Section
Business (233192)
Career Advice (4144)
Deals (39852)
Drug Delivery (145)
Drug Development (91386)
Employer Resources (203)
FDA (18371)
Job Trends (17415)
News (397782)
Policy (39955)
Tag
Academia (3006)
Academic (2)
Accelerated approval (31)
Adcomms (36)
Allergies (139)
Alliances (56981)
ALS (176)
Alzheimer's disease (1774)
Antibody-drug conjugate (ADC) (319)
Approvals (18526)
Artificial intelligence (588)
Autoimmune disease (145)
Automation (34)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (198)
Biotechnology (488)
Bladder cancer (155)
Brain cancer (63)
Breast cancer (634)
Cancer (4822)
Cardiovascular disease (422)
Career advice (3566)
Career pathing (40)
CAR-T (296)
CDC (59)
Celiac Disease (1)
Cell therapy (800)
Cervical cancer (37)
Clinical research (76754)
Collaboration (1664)
Company closure (5)
Compensation (1106)
Complete response letters (68)
COVID-19 (2984)
CRISPR (94)
C-suite (784)
Cystic fibrosis (149)
Data (6027)
Decentralized trials (2)
Denatured (69)
Depression (138)
Diabetes (511)
Diagnostics (7193)
Digital health (43)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (288)
Drug pricing (213)
Drug shortages (36)
Duchenne muscular dystrophy (228)
Earnings (99923)
Editorial (60)
Employer branding (25)
Employer resources (173)
Events (134776)
Executive appointments (1013)
FDA (21364)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (7)
Frontotemporal dementia (22)
Funding (1470)
Gene editing (205)
Generative AI (60)
Gene therapy (641)
GLP-1 (1101)
Government (5430)
Grass and pollen (8)
Guidances (381)
Healthcare (20941)
HIV (56)
Huntington's disease (46)
IgA nephropathy (84)
Immunology and inflammation (281)
Immuno-oncology (45)
Indications (80)
Infectious disease (3260)
Inflammatory bowel disease (199)
Inflation Reduction Act (17)
Influenza (116)
Intellectual property (229)
Interviews (816)
IPO (17948)
IRA (60)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (88)
Layoffs (653)
Leadership (39)
Legal (10156)
Liver cancer (97)
Longevity (14)
Lung cancer (661)
Lymphoma (368)
Machine learning (40)
Management (66)
Manufacturing (780)
MASH (170)
Medical device (14990)
Medtech (15033)
Mergers & acquisitions (22919)
Metabolic disorders (1335)
Multiple sclerosis (155)
NASH (23)
Neurodegenerative disease (331)
Neuropsychiatric disorders (90)
Neuroscience (3016)
NextGen: Class of 2026 (7705)
Non-profit (5107)
Now hiring (62)
Obesity (643)
Opinion (329)
Ovarian cancer (158)
Pain (194)
Pancreatic cancer (214)
Parkinson's disease (281)
Partnered (37)
Patents (482)
Patient recruitment (440)
Peanut (59)
People (66725)
Pharmaceutical (145)
Pharmacy benefit managers (31)
Phase I (23710)
Phase II (33301)
Phase III (25115)
Pipeline (4298)
Policy (325)
Postmarket research (3554)
Preclinical (10677)
Press Release (72)
Prostate cancer (234)
Psychedelics (53)
Radiopharmaceuticals (295)
Rare diseases (833)
Real estate (7437)
Recruiting (80)
Regulatory (28750)
Reports (65)
Research institute (2719)
Resumes & cover letters (651)
Rett syndrome (25)
RNA editing (16)
RSV (82)
Schizophrenia (153)
Series A (244)
Series B (180)
Service/supplier (30)
Sickle cell disease (102)
Special edition (27)
Spinal muscular atrophy (174)
Sponsored (47)
Startups (4329)
State (2)
Stomach cancer (19)
Supply chain (110)
Tariffs (97)
The Weekly (118)
Vaccines (1118)
Venture capital (84)
Weight loss (446)
Women's health (81)
Worklife (21)
Date
Today (224)
Last 7 days (485)
Last 30 days (1950)
Last 365 days (33389)
2026 (485)
2025 (33229)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1288)
Alabama (86)
Alaska (7)
Arizona (334)
Arkansas (14)
Asia (51435)
Australia (9025)
California (11058)
Canada (3221)
China (1104)
Colorado (467)
Connecticut (485)
Delaware (335)
Europe (118148)
Florida (1622)
Georgia (355)
Hawaii (3)
Idaho (68)
Illinois (920)
India (63)
Indiana (527)
Iowa (23)
Japan (405)
Kansas (131)
Kentucky (42)
Louisiana (29)
Maine (81)
Maryland (1416)
Massachusetts (8197)
Michigan (348)
Minnesota (639)
Mississippi (6)
Missouri (136)
Montana (34)
Nebraska (28)
Nevada (120)
New Hampshire (82)
New Jersey (3011)
New Mexico (32)
New York (2949)
North Carolina (1558)
North Dakota (10)
Northern California (5239)
Ohio (337)
Oklahoma (22)
Oregon (53)
Pennsylvania (2229)
Puerto Rico (20)
Rhode Island (48)
South America (1656)
South Carolina (62)
South Dakota (1)
Southern California (4254)
Tennessee (170)
Texas (1749)
United States (40177)
Utah (332)
Vermont (1)
Virginia (277)
Washington D.C. (85)
Washington State (933)
West Virginia (4)
Wisconsin (119)
Wyoming (2)
There are 868,175 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Podcast
Novo Launches Oral Obesity Pill, Lilly Targets Lofty Revenue, FDA and M&A in Focus
Novo Nordisk follows Christmas oral Wegovy approval with quick launch; Eli Lilly is headed for $94.3 billion in annual revenue by 2027, analysts predict; nine more pharmas strike Most Favored Nation deals but half remain unsigned; experts call for stability and rare disease action at FDA, and all eyes are on M&A ahead of the J.P. Morgan Healthcare conference next week.
January 7, 2026
·
2 min read
·
Heather McKenzie
Press Releases
Stallergenes Greer Expands Venom Immunotherapy Production Capacity With Acquisition of Entomon s.r.l.
January 7, 2026
·
5 min read
Press Releases
LIfT BioSciences Announces CEO Transition to Drive Next Phase of Growth with Neutrophil-based Therapies
January 7, 2026
·
4 min read
Press Releases
DISCO Pharmaceuticals Enters License Agreement to Advance Novel Cancer Surfaceome Targeted Therapies
January 7, 2026
·
2 min read
Press Releases
Scenic Biotech Enters License and Research Agreement with Ono Pharmaceutical
January 7, 2026
·
2 min read
Press Releases
RoslinCT and BOOST Pharma Announce Strategic Manufacturing Agreement to Advance Cell Therapy for Infants with Osteogenesis Imperfecta
January 7, 2026
·
4 min read
Press Releases
Daiichi Sankyo and GENESIS Pharma Enter Exclusive Agreement for VANFLYTA® Commercialization in Central and Eastern Europe
January 7, 2026
·
4 min read
Press Releases
Ionis partner GSK announces positive topline results from B-Well 1 and B-Well 2 Phase 3 studies for bepirovirsen, a potential first-in-class medicine for chronic hepatitis B
January 7, 2026
·
7 min read
Press Releases
Correction: JJP Biologics Announces Positive Top-Line Phase I Trial Results of JJP-1212, its anti-CD89 antagonist
January 7, 2026
·
4 min read
Press Releases
World-renowned Immunologist and Distinguished Scientist Joins CancerVax as Senior Scientific Advisor
January 7, 2026
·
4 min read
1 of 86,818
Next
